Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Research article

Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution

Authors: Yoshifumi Hamasaki, Kent Doi, Mototsugu Tanaka, Haruki Kume, Yoshitaka Ishibashi, Yutaka Enomoto, Toshiro Fujita, Yukio Homma, Masaomi Nangaku, Eisei Noiri

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Cardiovascular disease is a frequent cause of death in peritoneal dialysis patients. Biocompatible peritoneal dialysis solutions with neutral pH have been anticipated to reduce cardiovascular disease more than conventional peritoneal dialysis solutions with low pH, but it remains unclear which factors at peritoneal dialysis initiation increase cardiovascular risk in patients using biocompatible peritoneal dialysis solutions. This study was undertaken to investigate which clinical factors at peritoneal dialysis initiation, including peritoneal transport status, are associated with cardiovascular event in patients using biocompatible peritoneal dialysis solution.

Methods

This retrospective cohort study of peritoneal dialysis patients using biocompatible solutions with neutral pH assessed relations of clinical parameters at peritoneal dialysis initiation to cardiovascular event during the subsequent five years.

Results

Of 102 patients who started peritoneal dialysis, cardiovascular event occurred in 18. Age, history of cardiovascular disease before peritoneal dialysis initiation, hemoglobin, serum albumin, C-reactive protein, peritoneal permeability defined by the ratio of dialysate to plasma creatinine concentration at 4 hr (D/Pcre) in peritoneal equilibration test (PET), number of patients in each PET category defined by D/Pcre, and peritoneal protein clearance significantly differed between patients with and without cardiovascular event. For patients divided according to PET category using Kaplan–Meier method, the group of high average to high peritoneal transporters exhibited significantly high incidence of cardiovascular event and mortality compared with the groups of low and low-average peritoneal transporters (Log rank; p = 0.0003 and 0.005, respectively). A Cox proportional hazards model showed independent association of PET category classification with cardiovascular event.

Conclusions

Peritoneal permeability expressed as PET category at peritoneal dialysis initiation is an independent cardiovascular risk factor in peritoneal dialysis patients using biocompatible peritoneal dialysis solution with neutral pH. Greater peritoneal permeability at peritoneal dialysis initiation might reflect subclinical vascular disorders.
Appendix
Available only for authorised users
Literature
1.
go back to reference de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, Wetzels JF, Rosendaal FR, Dekker FW: Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009, 302 (16): 1782-1789. 10.1001/jama.2009.1488.CrossRefPubMed de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, Wetzels JF, Rosendaal FR, Dekker FW: Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009, 302 (16): 1782-1789. 10.1001/jama.2009.1488.CrossRefPubMed
2.
go back to reference Lameire N, Van Biesen W: Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol. 2010, 6 (2): 75-82. 10.1038/nrneph.2009.210.CrossRefPubMed Lameire N, Van Biesen W: Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol. 2010, 6 (2): 75-82. 10.1038/nrneph.2009.210.CrossRefPubMed
3.
go back to reference Krediet RT, Balafa O: Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol. 2010, 6 (8): 451-460. 10.1038/nrneph.2010.68.CrossRefPubMed Krediet RT, Balafa O: Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol. 2010, 6 (8): 451-460. 10.1038/nrneph.2010.68.CrossRefPubMed
4.
go back to reference Perez-Fontan M, Rodriguez-Carmona A, Barreda D, Lopez-Muniz A, Blanco-Castro N, Garcia-Falcon T: Peritoneal protein transport during the baseline peritoneal equilibration test is an accurate predictor of the outcome of peritoneal dialysis patients. Nephron Clin Pract. 2010, 116 (2): c104-c113. 10.1159/000314659.CrossRefPubMed Perez-Fontan M, Rodriguez-Carmona A, Barreda D, Lopez-Muniz A, Blanco-Castro N, Garcia-Falcon T: Peritoneal protein transport during the baseline peritoneal equilibration test is an accurate predictor of the outcome of peritoneal dialysis patients. Nephron Clin Pract. 2010, 116 (2): c104-c113. 10.1159/000314659.CrossRefPubMed
5.
go back to reference Perl J, Huckvale K, Chellar M, John B, Davies SJ: Peritoneal protein clearance and not peritoneal membrane transport status predicts survival in a contemporary cohort of peritoneal dialysis patients. Clin J Am Soc Nephrol. 2009, 4 (7): 1201-1206. 10.2215/CJN.01910309.CrossRefPubMedPubMedCentral Perl J, Huckvale K, Chellar M, John B, Davies SJ: Peritoneal protein clearance and not peritoneal membrane transport status predicts survival in a contemporary cohort of peritoneal dialysis patients. Clin J Am Soc Nephrol. 2009, 4 (7): 1201-1206. 10.2215/CJN.01910309.CrossRefPubMedPubMedCentral
6.
go back to reference Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP: Peritoneal equilibration test. Periton Dialys B. 1987, 7 (3): 138-147. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP: Peritoneal equilibration test. Periton Dialys B. 1987, 7 (3): 138-147.
7.
go back to reference Elsurer R, Afsar B, Sezer S, Ozdemir FN, Haberal M: Peritoneal albumin leakage: 2 year prospective cardiovascular event occurrence and patient survival analysis. Nephrology (Carlton). 2009, 14 (8): 712-715. 10.1111/j.1440-1797.2009.01103.x.CrossRef Elsurer R, Afsar B, Sezer S, Ozdemir FN, Haberal M: Peritoneal albumin leakage: 2 year prospective cardiovascular event occurrence and patient survival analysis. Nephrology (Carlton). 2009, 14 (8): 712-715. 10.1111/j.1440-1797.2009.01103.x.CrossRef
8.
go back to reference National Kidney Foundation: Clinical practice recommendations for peritoneal dialysis adequacy. Am J Kidney Dis. 2006, 48 Suppl 1: S130-S158. National Kidney Foundation: Clinical practice recommendations for peritoneal dialysis adequacy. Am J Kidney Dis. 2006, 48 Suppl 1: S130-S158.
9.
go back to reference Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1998, 9 (7): 1285-1292.PubMed Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1998, 9 (7): 1285-1292.PubMed
10.
go back to reference Rumpsfeld M, McDonald SP, Johnson DW: Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol. 2006, 17 (1): 271-278.CrossRefPubMed Rumpsfeld M, McDonald SP, Johnson DW: Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol. 2006, 17 (1): 271-278.CrossRefPubMed
11.
go back to reference Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG: Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol. 2006, 17 (9): 2591-2598. 10.1681/ASN.2006030194.CrossRefPubMed Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG: Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol. 2006, 17 (9): 2591-2598. 10.1681/ASN.2006030194.CrossRefPubMed
12.
go back to reference Garcia-Lopez E, Lindholm B, Davies S: An update on peritoneal dialysis solutions. Nat Rev Nephrol. 2012, 8 (4): 224-233. 10.1038/nrneph.2012.13.CrossRefPubMed Garcia-Lopez E, Lindholm B, Davies S: An update on peritoneal dialysis solutions. Nat Rev Nephrol. 2012, 8 (4): 224-233. 10.1038/nrneph.2012.13.CrossRefPubMed
13.
go back to reference Cho Y, Johnson DW, Badve SV, Craig JC, Strippoli GF, Wiggins KJ: The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int. 2013, 84 (5): 969-979. 10.1038/ki.2013.190.CrossRefPubMed Cho Y, Johnson DW, Badve SV, Craig JC, Strippoli GF, Wiggins KJ: The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients. Kidney Int. 2013, 84 (5): 969-979. 10.1038/ki.2013.190.CrossRefPubMed
14.
15.
go back to reference Haag-Weber M, Kramer R, Haake R, Islam MS, Prischl F, Haug U, Nabut JL, Deppisch R: Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study. Nephrol Dial Transplant. 2010, 25 (7): 2288-2296. 10.1093/ndt/gfq087.CrossRefPubMed Haag-Weber M, Kramer R, Haake R, Islam MS, Prischl F, Haug U, Nabut JL, Deppisch R: Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study. Nephrol Dial Transplant. 2010, 25 (7): 2288-2296. 10.1093/ndt/gfq087.CrossRefPubMed
16.
go back to reference Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J: The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int. 2004, 66 (1): 408-418. 10.1111/j.1523-1755.2004.00747.x.CrossRefPubMed Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, Passlick-Deetjen J: The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int. 2004, 66 (1): 408-418. 10.1111/j.1523-1755.2004.00747.x.CrossRefPubMed
17.
go back to reference Park SH, Do JY, Kim YH, Lee HY, Kim BS, Shin SK, Kim HC, Chang YK, Yang JO, Chung HC, Kim CD, Lee WK, Kim JY, Kim YL: Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study. Nephrol Dial Transplant. 2012, 27 (3): 1191-1199. 10.1093/ndt/gfr451.CrossRefPubMed Park SH, Do JY, Kim YH, Lee HY, Kim BS, Shin SK, Kim HC, Chang YK, Yang JO, Chung HC, Kim CD, Lee WK, Kim JY, Kim YL: Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study. Nephrol Dial Transplant. 2012, 27 (3): 1191-1199. 10.1093/ndt/gfr451.CrossRefPubMed
18.
go back to reference Margetts PJ, McMullin JP, Rabbat CG, Churchill DN: Peritoneal membrane transport and hypoalbuminemia: cause or effect?. Perit Dial Int. 2000, 20 (1): 14-18.PubMed Margetts PJ, McMullin JP, Rabbat CG, Churchill DN: Peritoneal membrane transport and hypoalbuminemia: cause or effect?. Perit Dial Int. 2000, 20 (1): 14-18.PubMed
19.
go back to reference Heaf JG, Sarac S, Afzal S: A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients. Nephrol Dial Transplant. 2005, 20 (10): 2194-2201. 10.1093/ndt/gfi008.CrossRefPubMed Heaf JG, Sarac S, Afzal S: A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients. Nephrol Dial Transplant. 2005, 20 (10): 2194-2201. 10.1093/ndt/gfi008.CrossRefPubMed
20.
go back to reference Wiggins KJ, McDonald SP, Brown FG, Rosman JB, Johnson DW: High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant. 2007, 22 (10): 3005-3012. 10.1093/ndt/gfm324.CrossRefPubMed Wiggins KJ, McDonald SP, Brown FG, Rosman JB, Johnson DW: High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant. 2007, 22 (10): 3005-3012. 10.1093/ndt/gfm324.CrossRefPubMed
21.
go back to reference Johnson DW, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Badve SV: Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2010, 25 (6): 1973-1979. 10.1093/ndt/gfp780.CrossRefPubMed Johnson DW, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Badve SV: Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2010, 25 (6): 1973-1979. 10.1093/ndt/gfp780.CrossRefPubMed
22.
go back to reference Yang X, Fang W, Bargman JM, Oreopoulos DG: High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis. Perit Dial Int. 2008, 28 (1): 82-92.PubMed Yang X, Fang W, Bargman JM, Oreopoulos DG: High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis. Perit Dial Int. 2008, 28 (1): 82-92.PubMed
23.
go back to reference van Biesen W, Heimburger O, Krediet R, Rippe B, La Milia V, Covic A, Vanholder R: Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group. Nephrol Dial Transplant. 2010, 25 (7): 2052-2062. 10.1093/ndt/gfq100.CrossRefPubMed van Biesen W, Heimburger O, Krediet R, Rippe B, La Milia V, Covic A, Vanholder R: Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group. Nephrol Dial Transplant. 2010, 25 (7): 2052-2062. 10.1093/ndt/gfq100.CrossRefPubMed
Metadata
Title
Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution
Authors
Yoshifumi Hamasaki
Kent Doi
Mototsugu Tanaka
Haruki Kume
Yoshitaka Ishibashi
Yutaka Enomoto
Toshiro Fujita
Yukio Homma
Masaomi Nangaku
Eisei Noiri
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-173

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.